Unknown

Dataset Information

0

Toward precision adjuvants: optimizing science and safety.


ABSTRACT: PURPOSE OF REVIEW:The gradual replacement of inactivated whole cell and live attenuated vaccines with subunit vaccines has generally reduced reactogenicity but in many cases also immunogenicity. Although only used when necessary, adjuvants can be key to vaccine dose/antigen-sparing, broadening immune responses to variable antigens, and enhancing immunogenicity in vulnerable populations with distinct immunity. Licensed vaccines contain an increasing variety of adjuvants, with a growing pipeline of adjuvanted vaccines under development. RECENT FINDINGS:Most adjuvants, including Alum, Toll-like receptor agonists and oil-in-water emulsions, activate innate immunity thereby altering the quantity and quality of an adaptive immune response. Adjuvants activate leukocytes, and induce mediators (e.g., cytokines, chemokines, and prostaglandin-E2) some of which are biomarkers for reactogenicity, that is, induction of local/systemic side effects. Although there have been safety concerns regarding a hypothetical risk of adjuvants inducing auto-immunity, such associations have not been established. As immune responses vary by population (e.g., age and sex), adjuvant research now incorporates principles of precision medicine. Innovations in adjuvant research include use of human in vitro models, immuno-engineering, novel delivery systems, and systems biology to identify biomarkers of safety and adjuvanticity. SUMMARY:Adjuvants enhance vaccine immunogenicity and can be associated with reactogenicity. Novel multidisciplinary approaches hold promise to accelerate and de-risk targeted adjuvant discovery and development. VIDEO ABSTRACT: http://links.lww.com/MOP/A53.

SUBMITTER: Nanishi E 

PROVIDER: S-EPMC6970548 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Toward precision adjuvants: optimizing science and safety.

Nanishi Etsuro E   Dowling David J DJ   Levy Ofer O  

Current opinion in pediatrics 20200201 1


<h4>Purpose of review</h4>The gradual replacement of inactivated whole cell and live attenuated vaccines with subunit vaccines has generally reduced reactogenicity but in many cases also immunogenicity. Although only used when necessary, adjuvants can be key to vaccine dose/antigen-sparing, broadening immune responses to variable antigens, and enhancing immunogenicity in vulnerable populations with distinct immunity. Licensed vaccines contain an increasing variety of adjuvants, with a growing pi  ...[more]

Similar Datasets

| S-EPMC4128316 | biostudies-literature
| S-EPMC6358458 | biostudies-literature
| S-EPMC8023785 | biostudies-literature
| S-EPMC5985668 | biostudies-other
| S-EPMC9376277 | biostudies-literature
| S-EPMC5986937 | biostudies-other
| S-EPMC6468710 | biostudies-literature
| S-EPMC8278159 | biostudies-literature
| S-EPMC6688754 | biostudies-literature
| S-EPMC2842060 | biostudies-literature